 CTI BioPharma Corp. NASDAQ:CTIC Q3 2022 Results Earnings Conference Call November 8, 2022 4:30 PM ET Company Participants Adam Craig - President, Chief Executive Officer and Interim Chief Medical Officer James Fong - Executive Vice President and Chief Commercial Officer David Kirske - Executive Vice President and Chief Financial Officer Conference Call Participants Kelly Shi - Jefferies Kenneth Shields - SVB Securities Bert Hazlett - BTIG Benjamin Burnett - Stifel Reni Benjamin - JMP Securities Gil Blum - Needham Company Thomas Flaten - Lake Street Capital Markets Operator Good afternoon. Thank you for standing by. 